IUHSA
FDMT icon

Itau Unibanco Holding S.A.’s 4D Molecular Therapeutics FDMT Stock Holding History

Itau Unibanco Holding S.A.’s Portfolio FDMT Stock Details FDMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1,646
Closed -$33.3K – 210
2023
Q4 		$33.3K Buy
1,646
+147
+10% +$1.93K ﹤0.01% 234
2023
Q3 		$19.1K Buy
1,499
+366
+32% +$6.12K ﹤0.01% 372
2023
Q2 		$20.5K Buy
+1,133
New +$20.9K ﹤0.01% 410

Other funds holding FDMT

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Itau Unibanco Holding S.A.'s FDMT Position: Q1 2024 in Review

Itau Unibanco Holding S.A. sold out of 4D Molecular Therapeutics (FDMT) in Q1 2024, closing a stake of 1,646 shares — an estimated $33.3K sold.

Itau Unibanco Holding S.A. first reported a position in FDMT in Q2 2023 and held it in 3 quarters. The position peaked at $33.3K in Q4 2023. 147 funds tracked by Wall St. Rank hold FDMT as of Q1 2024.

  • Itau Unibanco Holding S.A. reported no remaining 4D Molecular Therapeutics position as of Q1 2024 after selling out during the quarter.
  • Itau Unibanco Holding S.A. sold 1,646 4D Molecular Therapeutics shares in Q1 2024, an estimated $33.3K.
  • Itau Unibanco Holding S.A. first reported a position in 4D Molecular Therapeutics in Q2 2023 and held it in 3 quarters.
  • Itau Unibanco Holding S.A.'s 4D Molecular Therapeutics position peaked at $33.3K in Q4 2023.
  • 147 funds tracked by Wall St. Rank held 4D Molecular Therapeutics as of Q1 2024.

Based on Itau Unibanco Holding S.A.'s 13F filing for Q1 2024, filed 14 May 2024.